Women's Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 - 2030

Report
100 Pages
September 2023
Region: Global
Grand View Research
ID: 4661562

The global women’s health diagnostics market size is expected to reach USD 31.4 billion by 2030. The market is expected to expand at a CAGR of 7.3% from 2023 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women’s health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights

Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
Geographically, North America dominated the market and accounted for the largest revenue share of 44.87% in 2022. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End-use
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Women’s Health Diagnostic Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Women’s Health Diagnostic Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies

Chapter 4. Women’s Health Diagnostic: Application Estimates & Trend Analysis

4.1. Women’s Health Diagnostic Market: Key Takeaways
4.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Cancer
4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Infectious diseases
4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Osteoporosis
4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Pregnancy & fertility
4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Prenatal
4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Women’s Health Diagnostic: End-use Estimates & Trend Analysis

5.1. Women’s Health Diagnostic Market: Key Takeaways
5.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Laboratory
5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Women’s Health Diagnostic Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook
6.2. Women’s Health Diagnostic Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. F. Hoffmann-la Roche Ltd.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Siemens Aktiengeselischaft
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Quest Diagnostics incorporated
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Ge Healthcare
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Koninklijke Philips N.V.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Abbott Laboratories
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Becton, Dickinson and Company
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Hologic, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 3 North America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 8 Canada women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 10 Europe women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 12 Germany women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 13 Germany women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 15 UK women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 16 France women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 17 France women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 19 Italy women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 21 Spain women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 23 Sweden women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 25 Norway women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 27 Denmark women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 31 China women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 32 China women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 34 Japan women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 35 India women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 36 India women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 37 Thailand women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 38 Thailand women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 39 South Korea women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 42 Australia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 47 Brazil women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 49 Mexico women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 56 South Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 60 UAE women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 62 Kuwait women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Women’s health diagnostics: market outlook
Fig. 9 Women’s health diagnostics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Women’s health diagnostics market driver impact
Fig. 15 Women’s health diagnostics market restraint impact
Fig. 16 Women’s health diagnostics market strategic initiatives analysis
Fig. 17 Women’s health diagnostics market: Application movement analysis
Fig. 18 Women’s health diagnostics market: Application outlook and key takeaways
Fig. 19 Cancer market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 20 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 21 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 22 Pregnancy & fertility market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 23 Prenatal market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 24 Women’s health diagnostics market: End-use movement analysis
Fig. 25 Women’s health diagnostics market: End-use outlook and key takeaways
Fig. 26 Hospital market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 27 Laboratory market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 28 Homecare market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 30 Global women’s health diagnostics market: Regional movement analysis
Fig. 31 Global women’s health diagnostics market: Regional outlook and key takeaways
Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Millions)
Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Millions)

Companies Mentioned

F. Hoffmann-la Roche Ltd.
Siemens Aktiengeselischaft
Quest Diagnostics incorporated
Ge Healthcare
Koninklijke Philips N.V.
Abbott Laboratories
Becton, Dickinson and Company
Hologic, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	100
Published	September 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 17.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 31.4 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	8

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5779EUR$5,950USD£4,937GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6750EUR$6,950USD£5,767GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8693EUR$8,950USD£7,426GBP

Women's Health Diagnostics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Women's Health Therapeutics Market by Type (Infection, Oncology, Pregnancy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Forecast 2024-2030

Global Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report by Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Region, and Segment Forecasts, 2024-2030

Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

Global Pregnancy Detection Kits - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global Non-invasive Prenatal Testing Market by Product (Consumables, Instruments), Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests), Application, End User - Forecast 2024-2030